Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder

Psychopharmacology

Volumn 231, Issue 15, 2014, Pages 3019-3029

  Miller, Erin M ^a   Pomerleau, Francois ^a   Huettl, Peter ^a   Gerhardt, Greg A ^a   Glaser, Paul E A ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Glutamate; Glutamate release; Glutamate uptake; Prefrontal cortex; Spontaneously hypertensive rat; Striatum; Wistar Kyoto rat

Indexed keywords

DOPAMINE; GLUTAMIC ACID; CENTRAL NERVOUS SYSTEM AGENTS; POTASSIUM CHLORIDE;

AMINO ACID TRANSPORT; AMPEROMETRY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; CINGULATE GYRUS; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; GLUTAMATE RELEASE; GLUTAMATE UPTAKE; GLUTAMATERGIC SYSTEM; IN VIVO STUDY; INFRALIMBIC CORTEX; LIMIT OF DETECTION; MALE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MONOAMINERGIC SYSTEM; NEUROCHEMISTRY; NEUROPATHOLOGY; NEUROSECRETION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRELIMBIC CORTEX; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; DISEASE MODEL; DRUG EFFECTS; METABOLISM; MICROELECTRODE; PATHOPHYSIOLOGY; WISTAR KYOTO RAT;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM AGENTS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GLUTAMIC ACID; MALE; MICROELECTRODES; NUCLEUS ACCUMBENS; POTASSIUM CHLORIDE; PREFRONTAL CORTEX; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 84904428920     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3479-4     Document Type: Article

References (66)

1. Adey WR (1951) An experimental study of the hippocampal connexions of the cingulate cortex in the rabbit. Brain: J Neurol 74(2):233-247
2. Adey WR, Meyer M (1952) An experimental study of hippocampal afferent pathways from prefrontal and cingulate areas in the monkey. J Anat 86(1):58-74
3. Andreollo NA, Santos EF, Araujo MR, Lopes LR (2012) Rat's age versus human's age: what is the relationship? Arq Bras Cir Dig 25(1):49-51
4. Arnsten AF (2009) Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs 23(Suppl 1):33-41. doi:10.2165/00023210-200923000-00005
5. Arnsten AF, Li BM (2005) Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57(11):1377-1384. doi:10.1016/j.biopsych.2004.08.019 (Pubitemid 40798558)
6. Balleine BW, Delgado MR, Hikosaka O (2007) The role of the dorsal striatum in reward and decision-making. J Neurosci 27(31):8161-8165. doi:10.1523/JNEUROSCI.1554-07.2007 (Pubitemid 47219597)
7. Berridge CW, Shumsky JS, Andrzejewski ME, McGaughy JA, Spencer RC, Devilbiss DM, Waterhouse BD (2012) Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic alpha(1) - and alpha(2)-receptors. Biol Psychiatry 71(5):467-473. doi:10.1016/j.biopsych.2011.07.022
8. Brassett-Harknett A, Butler N (2007) Attention-deficit/hyperactivity disorder: an overview of the etiology and a review of the literature relating to the correlates and lifecourse outcomes for men and women. Clin Psychol Rev 27(2):188-210. doi:10.1016/j.cpr.2005.06.001 (Pubitemid 46123123)
9. Burmeister JJ, Gerhardt GA (2001) Self-referencing ceramic-based multisite microelectrodes for the detection and elimination of interferences from the measurement of L-glutamate and other analytes. Anal Chem 73(5):1037-1042 (Pubitemid 32204921)
10. Cascade E, Kalali AH, Wigal SB (2010) Real-world data on: attention deficit hyperactivity disorder medication side effects. Psychiatry (Edgmont) 7(4):13-15
11. Cass WA, Gerhardt GA (1995) In vivo assessment of dopamine uptake in rat medial prefrontal cortex: comparison with dorsal striatum and nucleus accumbens. J Neurochem 65(1):201-207
12. Cass WA, Gerhardt GA, Mayfield RD, Curella P, Zahniser NR (1992) Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J Neurochem 59(1):259-266
13. Cass WA, Zahniser NR, Flach KA, Gerhardt GA (1993) Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. J Neurochem 61(6):2269-2278 (Pubitemid 23354088)
14. Charach A, Yeung E, Climans T, Lillie E (2011) Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 50(1):9-21. doi:10.1016/j.jaac.2010.09.019
15. Cowles BJ (2009) Update on the management of attention-deficit/ hyperactivity disorder in children and adults: patient considerations and the role of lisdexamfetamine. Ther Clin Risk Manag 5:943-948
16. Dalley JW, Cardinal RN, Robbins TW (2004) Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28(7):771-784. doi:10.1016/j.neubiorev.2004.09.006 (Pubitemid 39535871)
17. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65(1):1-105
18. Dramsdahl M, Ersland L, Plessen KJ, Haavik J, Hugdahl K, Specht K (2011) Adults with attention-deficit/hyperactivity disorder - a brain magnetic resonance spectroscopy study. Front Psychiatr 2:65. doi:10.3389/fpsyt.2011.00065
19. Dunnett SB, Lelos M (2010) Behavioral analysis of motor and non-motor symptoms in rodent models of Parkinson's disease. Prog Brain Res 184:35-51. doi:10.1016/S0079-6123(10)84003-8
20. Findling RL, McNamara NK, Stansbrey RJ, Maxhimer R, Periclou A, Mann A, Graham SM (2007) A pilot evaluation of the safety, tolerability, pharmacokinetics, and effectiveness of memantine in pediatric patients with attention-deficit/hyperactivity disorder combined type. J Child Adolesc Psychopharmacol 17(1):19-33. doi:10.1089/cap.2006.0044 (Pubitemid 46452079)
21. Friedemann MN, Gerhardt GA (1992) Regional effects of aging on dopaminergic function in the Fischer-344 rat. Neurobiol Aging 13(2):325-332. doi:10.1016/0197-4580(92)90046-Z
22. Granziera C, Hadjikhani N, Arzy S, Seeck M, Meuli R, Krueger G (2011) In-vivo magnetic resonance imaging of the structural core of the Papez circuit in humans. Neuroreport 22(5):227-231. doi:10.1097/WNR.0b013e328344f75f
23. Halperin JM, Schulz KP (2006) Revisiting the role of the prefrontal cortex in the pathophysiology of attention-deficit/hyperactivity disorder. Psychol Bull 132(4):560-581. doi:10.1037/0033-2909.132.4.560 (Pubitemid 44212071)
24. Hammerness P, Biederman J, Petty C, Henin A, Moore CM (2012) Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention-deficit hyperactivity disorder: a controlled pilot study. CNS Neurosci Ther 18(1):34-40. doi:10.1111/j.1755-5949. 2010.00226.x
25. Hascup ER, Hascup KN, Stephens M, Pomerleau F, Huettl P, Gratton A, Gerhardt GA (2010) Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex. J Neurochem 115(6):1608-1620. doi:10.1111/j.1471-4159.2010.07066.x
26. Hebert MA, Larson GA, Zahniser NR, Gerhardt GA (1999) Age-related reductions in [3H]WIN 35,428 binding to the dopamine transporter in nigrostriatal and mesolimbic brain regions of the Fischer 344 rat. J Pharmacol Exp Ther 288(3):1334-1339 (Pubitemid 29254175)
27. Hinzman JM, Thomas TC, Burmeister JJ, Quintero JE, Huettl P, Pomerleau F, Gerhardt GA, Lifshitz J (2010) Diffuse brain injury elevates tonic glutamate levels and potassium-evoked glutamate release in discrete brain regions at two days post-injury: an enzyme-based microelectrode array study. J Neurotrauma 27(5):889-899. doi:10.1089/neu.2009.1238
28. Hinzman JM, Thomas TC, Quintero JE, Gerhardt GA, Lifshitz J (2012) Disruptions in the regulation of extracellular glutamate by neurons and glia in the rat striatum two days after diffuse brain injury. J Neurotrauma 29(6):1197-1208. doi:10.1089/neu.2011.2261
29. Hoffman AF, Gerhardt GA (1998) In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions. J Neurochem 70(1):179-189 (Pubitemid 28020842)
30. Johansen EB, Killeen PR, Russell VA, Tripp G, Wickens JR, Tannock R, Williams J, Sagvolden T (2009) Origins of altered reinforcement effects in ADHD. Behav Brain Funct 5:7. doi:10.1186/1744-9081-5-7
31. Kahn JB, Ward RD, Kahn LW, Rudy NM, Kandel ER, Balsam PD, Simpson EH (2012) Medial prefrontal lesions in mice impair sustained attention but spare maintenance of information in working memory. Learn Mem 19(11):513-517. doi:10.1101/lm.026302.112
32. Klimkeit EI, Mattingley JB, Sheppard DM, Lee P, Bradshaw JL (2005) Motor preparation, motor execution, attention, and executive functions in attention deficit/hyperactivity disorder (ADHD). Child Neuropsychol 11(2):153-173. doi:10.1080/092970490911298 (Pubitemid 40677042)
33. Knardahl S, Sagvolden T (1979) Open-field behavior of spontaneously hypertensive rats. Behav Neural Biol 27(2):187-200 (Pubitemid 10192099)
34. Knardahl S, Sagvolden T (1981) Regarding hyperactivity of the SHR in the open-field test. Behav Neural Biol 32(2):274-275
35. Kotecha SA, Oak JN, Jackson MF, Perez Y, Orser BA, Van Tol HH, MacDonald JF (2002) A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 35(6):1111-1122 (Pubitemid 35279538)
36. Krause KH, Dresel SH, Krause J, la Fougere C, Ackenheil M (2003) The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci Biobehav Rev 27(7):605-613 (Pubitemid 37414909)
37. Krusch DA, Klorman R, Brumaghim JT, Fitzpatrick PA, Borgstedt AD, Strauss J (1996) Methylphenidate slows reactions of children with attention deficit disorder during and after an error. J Abnorm Child Psychol 24(5):633-650 (Pubitemid 26408776)
38. Lehohla M, Kellaway L, Russell VA (2004) NMDA receptor function in the prefrontal cortex of a ratmodel for attention-deficit hyperactivity disorder. Metab Brain Dis 19(1-2):35-42 (Pubitemid 39005623)
39. Levy F (1991) The dopamine theory of attention deficit hyperactivity disorder (ADHD). Aust N Z J Psychiatry 25(2):277-283
40. Mehta MA, Goodyer IM, Sahakian BJ (2004) Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry 45(2):293-305 (Pubitemid 38240276)
41. Miller EM, Pomerleau F, Huettl P, Russell VA, Gerhardt GA, Glaser PE (2012) The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens. Neuropharmacology 63(8):1327-1334. doi:10.1016/j. neuropharm.2012.08.020
42. Miller EM, Thomas TC, Gerhardt GA, Glaser PEA (2013) Dopamine and glutamate interactions in ADHD: implications for the future neuropharmacology of ADHD. In: Banerjee S (ed) Attention deficit hyperactivity disorder in children and adolescents. doi:10.5772/54207
43. Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K, Houck PR (2009) The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 48(5):484-500. doi:10.1097/CHI. 0b013e31819c23d0
44. Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, Dougherty M, Harpold T, Hammerness P, Randall E, Renshaw PF (2006) Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am J Psychiatry 163(2):316-318. doi:10.1176/appi.ajp.163.2. 316 (Pubitemid 44480854)
45. Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, Dougherty M, Harpold T, Hammerness P, Randall E, Lyoo IK, Renshaw PF (2007) Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J Affect Disord 99(1-3):19-25. doi:10.1016/j.jad.2006.08.023 (Pubitemid 46275021)
46. Paxinos G, Watson C (2009) The rat brain in stereotaxic coordinates, 6th edn. Academic Press/Elsevier, Amsterdam
47. Perry JL, Joseph JE, Jiang Y, Zimmerman RS, Kelly TH, Darna M, Huettl P, Dwoskin LP, Bardo MT (2011) Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions. Brain Res Rev 65(2):124-149. doi:10.1016/j.brainresrev.2010.09.001
48. Podet A, Lee MJ, Swann AC, Dafny N (2010) Nucleus accumbens lesions modulate the effects of methylphenidate. Brain Res Bull 82(5-6):293-301. doi:10.1016/j.brainresbull.2010.05.006
49. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164(6):942-948. doi:10.1176/appi.ajp.164.6.942 (Pubitemid 46972911)
50. Rastogi RB, Singhal RL (1976) Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain. J Pharmacol Exp Ther 198(3):609-618
51. Robbins TW, Sahakian BJ (1979) "Paradoxical" effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology. Neuropharmacology 18(12):931-950 (Pubitemid 10117383)
52. Russell VA (2000) The nucleus accumbens motor-limbic interface of the spontaneously hypertensive rat as studied in vitro by the superfusion slice technique. Neurosci Biobehav Rev 24(1):133-136
53. Russell VA (2001) Increased AMPA receptor function in slices containing the prefrontal cortex of spontaneously hypertensive rats. Metab Brain Dis 16(3-4):143-149
54. Russell VA (2011) Overview of animal models of attention deficit hyperactivity disorder (ADHD). Curr Protoc Neurosci Chapter 9:Unit9 35. doi:10.1002/0471142301.ns0935s54
55. Rutherford EC, Pomerleau F, Huettl P, Stromberg I, Gerhardt GA (2007) Chronic second-by-second measures of L-glutamate in the central nervous system of freely moving rats. J Neurochem 102(3):712-722. doi:10.1111/j.1471-4159.2007. 04596.x (Pubitemid 47057300)
56. Sagvolden T, Johansen EB (2012) Rat models of ADHD. Curr Top Behav Neurosci 9:301-315. doi:10.1007/7854-2011-126
57. Sagvolden T, Johansen EB, Aase H, Russell VA (2005) A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 28(3):397-419. doi:10.1017/S0140525X05000075, discussion 419-368
58. Sagvolden T, Dasbanerjee T, Zhang-James Y, Middleton F, Faraone S (2008) Behavioral and genetic evidence for a novel animal model of attention-deficit/ hyperactivity disorder predominantly inattentive subtype. Behav Brain Funct 4:56. doi:10.1186/1744-9081-4-56
59. Sagvolden T, Johansen EB, Woien G, Walaas SI, Storm-Mathisen J, Bergersen LH, Hvalby O, Jensen V, Aase H, Russell VA, Killeen PR, Dasbanerjee T, Middleton FA, Faraone SV (2009) The spontaneously hypertensive rat model of ADHD - the importance of selecting the appropriate reference strain. Neuropharmacology 57(7-8):619-626. doi:10.1016/j.neuropharm.2009.08.004
60. Salamone JD, Correa M (2012) The mysterious motivational functions of mesolimbic dopamine. Neuron 76(3):470-485. doi:10.1016/j.neuron.2012.10.021
61. Solanto MV, Arnsten AFT, Castellanos FX (2001) Stimulant drugs and ADHD: basic and clinical neuroscience. Oxford University Press, New York
62. Spencer TJ, Biederman J, Mick E (2007) Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol 32(6):631-642. doi:10.1093/jpepsy/jsm005
63. Surman CB, Hammerness PG, Petty C, Spencer T, Doyle R, Napolean S, Chu N, Yorks D, Biederman J (2012) A pilot open label prospective study of memantine monotherapy in adults with ADHD. World J Biol Psychiatry. doi:10.3109/15622975. 2011.623716
64. Thomas TC, Hinzman JM, Gerhardt GA, Lifshitz J (2012) Hypersensitive glutamate signaling correlates with the development of late-onset behavioralmorbidity in diffuse brain-injured circuitry. J Neurotrauma 29(2):187-200. doi:10.1089/neu.2011.2091
65. Warton FL, Howells FM, Russell VA (2009) Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/ hyperactivity disorder-lack of effect of methylphenidate. Metab Brain Dis 24(4):599-613. doi:10.1007/s11011-009-9166-1
66. Yuen EY, Zhong P, Yan Z (2010) Homeostatic regulation of glutamatergic transmission by dopamine D4 receptors. Proc Natl Acad Sci U S A 107(51):22308-22313. doi:10.1073/pnas.1010025108